These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1426024)

  • 1. Characterization of rat glomerular thromboxane A2 receptors: comparison to rat platelets.
    Folger WH; Halushka PV; Wilcox CS; Guzman NJ
    Eur J Pharmacol; 1992 Sep; 227(1):71-8. PubMed ID: 1426024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane binding and signal transduction in rat glomerular mesangial cells.
    Spurney RF; Onorato JJ; Albers FJ; Coffman TM
    Am J Physiol; 1993 Feb; 264(2 Pt 2):F292-9. PubMed ID: 8447439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
    Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
    J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.
    Masuda A; Mais DE; Oatis JE; Halushka PV
    Biochem Pharmacol; 1991 Jul; 42(3):537-44. PubMed ID: 1830482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets.
    Mayeux PR; Morinelli TA; Williams TC; Hazard ES; Mais DE; Oatis JE; Baron DA; Halushka PV
    J Biol Chem; 1991 Jul; 266(21):13752-8. PubMed ID: 1830308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of ligand binding to thromboxane A2/prostaglandin H2 receptors by diethylpyrocarbonate. Protection by receptor ligands and reversal by hydroxylamine.
    Schrör K; Davis-Bruno K; Halushka PV
    Biochem Pharmacol; 1995 Mar; 49(7):921-7. PubMed ID: 7741764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of human peripheral blood monocyte thromboxane A2 receptors.
    Allan CJ; Halushka PV
    J Pharmacol Exp Ther; 1994 Aug; 270(2):446-52. PubMed ID: 8071836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the vascular thromboxane A2/prostaglandin endoperoxide receptor in rabbit aorta. Regulation by dexamethasone.
    Sessa WC; Halushka PV; Okwu A; Nasjletti A
    Circ Res; 1990 Dec; 67(6):1562-9. PubMed ID: 2147131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimetic.
    Saussy DL; Mais DE; Dubé GP; Magee DE; Brune KA; Kurtz WL; Williams CM
    Mol Pharmacol; 1991 Jan; 39(1):72-8. PubMed ID: 1824791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist.
    Morinelli TA; Oatis JE; Okwu AK; Mais DE; Mayeux PR; Masuda A; Knapp DR; Halushka PV
    J Pharmacol Exp Ther; 1989 Nov; 251(2):557-62. PubMed ID: 2530338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
    Okwu AK; Ullian ME; Halushka PV
    J Pharmacol Exp Ther; 1992 Jul; 262(1):238-45. PubMed ID: 1378092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism for homologous downregulation of thromboxane A2 receptors in cultured human chronic myelogenous leukemia (K562) cells.
    Dorn GW
    J Pharmacol Exp Ther; 1991 Oct; 259(1):228-34. PubMed ID: 1833525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.
    Dorn GW
    J Clin Invest; 1989 Dec; 84(6):1883-91. PubMed ID: 2531760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue- and species-specific differences in ligand binding to thromboxane A2 receptors.
    Dorn GW
    Am J Physiol; 1991 Jul; 261(1 Pt 2):R145-53. PubMed ID: 1830459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane receptors in human kidney tissues.
    Brown GP; Venuto RC
    Prostaglandins Other Lipid Mediat; 1999 Jun; 57(4):179-88. PubMed ID: 10402213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and pharmacologic characterization of a thromboxane A2 receptor from K562 (human chronic myelogenous leukemia) cells.
    D'Angelo DD; Davis MG; Ali S; Dorn GW
    J Pharmacol Exp Ther; 1994 Nov; 271(2):1034-41. PubMed ID: 7965765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular thromboxane A2/prostaglandin H2 receptors: characterization and effect of adriamycin-induced nephrotic syndrome.
    Mayeux PR; Shah SV
    Biochim Biophys Acta; 1993 Apr; 1181(2):148-54. PubMed ID: 8481403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets.
    Matsuda K; Ruff A; Morinelli TA; Mathur RS; Halushka PV
    Am J Physiol; 1994 Sep; 267(3 Pt 2):H887-93. PubMed ID: 8092292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.
    Dorn GW; Becker MW; Davis MG
    J Biol Chem; 1992 Dec; 267(34):24897-905. PubMed ID: 1447225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of thromboxane receptor activation in rat glomerular mesangial cells.
    Spurney RF; Middleton JP; Raymond JR; Coffman TM
    Am J Physiol; 1994 Sep; 267(3 Pt 2):F467-78. PubMed ID: 8092261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.